Isracann Biosciences Inc. announced that Mr. James (JT) Thompson joins as Chief Operations Officer, Mr. Matt Chatterton moves to Chief Science Officer and Dr. George Vrabec, MD FRCSC (Urol.) joins as board director. The Company further advises that Mr. Darryl Jones has resigned from the board of directors and the Company thanks him for his diligent and timely efforts during the initial period of corporate development, including the turbulent pandemic years, and wishes him well on his future endeavours.